Cargando…
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort
Human epidermal growth factor receptor 2-positive breast cancer is a subtype of interest regarding its outcome and the impressive impact of human epidermal growth factor receptor 2 targeted therapy. Constitutional variants may be involved in the aetiology of human epidermal growth factor receptor 2-...
Ejemplares similares
-
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
por: Curtit, Elsa, et al.
Publicado: (2017) -
GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients
por: Cox, David G., et al.
Publicado: (2016) -
Married—Phares—Barfield
Publicado: (1868) -
Introduction of a collaborative quality improvement program in the French cystic fibrosis network: the PHARE-M initiative
por: Pougheon Bertrand, Dominique, et al.
Publicado: (2018) -
Quality of care in cystic fibrosis: assessment protocol of the French QIP PHARE-M
por: Pougheon Bertrand, Dominique, et al.
Publicado: (2018)